NCT05140733

Brief Summary

The present study was to see the effect of minimally invasive neural foraminotomy for lumbar foraminal stenosis with unilateral radicular pain. Traditionally, fusion was was done for the patients, but recent development enable surgeon to decompress neural foramen without rigid spinal fusion. Although, clinical effect of neural foraminotomy may have limitation in attaining a comparable result to fusion surgery, a cost-effective analysis may reveal a result in a different perspective. In this regard, we designed a prospective cohort study to see the cost-effectiveness of neural foraminotomy compared to fusion surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

August 22, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 1, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

2.5 years

First QC Date

August 22, 2021

Last Update Submit

March 13, 2024

Conditions

Keywords

Cost-effectivenesssurgerydeformity

Outcome Measures

Primary Outcomes (4)

  • Cost-effectiveness

    cost to increased one quality adjusted life year (QALY) after surgical treatment

    preoperation

  • Cost-effectiveness

    cost to increased one quality adjusted life year (QALY) after surgical treatment

    postoperative 6 months

  • Cost-effectiveness

    cost to increased one quality adjusted life year (QALY) after surgical treatment

    postoperative 1 year

  • Cost-effectiveness

    cost to increased one quality adjusted life year (QALY) after surgical treatment

    postoperative 2 years

Secondary Outcomes (8)

  • Oswestry disability index (ODI)

    preoperation

  • Oswestry disability index (ODI)

    postoperative 6 months

  • Oswestry disability index (ODI)

    postoperative 1 year

  • Oswestry disability index (ODI)

    postoperative 2 years

  • Numeric rating scale(NRS) of pain on back (NRS-B) and legs (NRS-L)

    preoperation

  • +3 more secondary outcomes

Study Arms (2)

Fusion

1 or 2 levels fusion surgery

Procedure: Fusion surgery

Foraminotomy

1 or 2 levels lumbar foraminotomy

Procedure: lumbar foraminal decompression

Interventions

lumbar foraminal decompression with endoscopic instruments.

Foraminotomy

Fusion surgery for patients with foraminal stenosis

Fusion

Eligibility Criteria

Age40 Years - 100 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

26 patients in each foraminotomy and fusion group.

You may qualify if:

  • patients between 40 - 100 years.
  • No improvement despite nonsurgical treatment for more than 3 months.
  • No history of lumbar fusion surgery.
  • Single or double-level lumbar foraminal stenosis with corresponding leg pain

You may not qualify if:

  • Severe neurological deficit (motor grade less than Grade III)
  • Combined inflammatory joint disease
  • Combined neurodegenerative disease such as Parkinson's disease or dementia \* Combined cancer, traumatic fracture
  • Marked spinal deformity (C7 sagittal vertical axis \> 10cm)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, Korea, 03080, South Korea

Location

MeSH Terms

Conditions

Congenital Abnormalities

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 22, 2021

First Posted

December 1, 2021

Study Start

August 22, 2021

Primary Completion

February 28, 2024

Study Completion

February 28, 2024

Last Updated

March 15, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

I am willing to share all data after publication.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
after publication of study results.

Locations